Differences in the pathological, transcriptomic, and prognostic implications of lymphoid structures between primary and metastatic cutaneous melanomas.
Karapetyan L, Li A, Vargas De Stefano D, Abushukair HM, Al-Bzour AN, Knight A, Layding C, Wang H, Xu J, Yao J, Song X, Joy M, Nguyen J, Moran-Segura C, Bruno S, Sander C, Messina J, Mule JJ, Storkus WJ, Kirkwood JM.
Karapetyan L, et al. Among authors: xu j.
J Immunother Cancer. 2024 Nov 12;12(11):e009231. doi: 10.1136/jitc-2024-009231.
J Immunother Cancer. 2024.
PMID: 39537211